Education
About Us
Working with TipRanks
Follow Us
Medipharm Labs (Otc) (TSE:LABS)
:LABS
LABS Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.06 - C$0.12
Previous CloseN/A
Volume690.59K
Average Volume (3M)233.41K
Market Cap
C$29.45M
Enterprise ValueC$19.25M
Total Cash (Recent Filing)C$10.36M
Total Debt (Recent Filing)C$542.00K
Price to Earnings (P/E)―
Beta0.71
Next Earnings
Nov 17, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding420,755,000
10 Day Avg. Volume168,459
30 Day Avg. Volume233,407
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
MediPharm Labs News
LABS FAQ
What was Medipharm Labs (Otc)’s price range in the past 12 months?
Medipharm Labs (Otc) lowest stock price was C$0.06 and its highest was C$0.12 in the past 12 months.
What is Medipharm Labs (Otc)’s market cap?
Medipharm Labs (Otc)’s market cap is C$29.45M.
When is Medipharm Labs (Otc)’s upcoming earnings report date?
Medipharm Labs (Otc)’s upcoming earnings report date is Nov 17, 2025 which is in 51 days.
How were Medipharm Labs (Otc)’s earnings last quarter?
Medipharm Labs (Otc) released its earnings results on Aug 14, 2025. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of -C$0.002 by -C$0.008.
Is Medipharm Labs (Otc) overvalued?
According to Wall Street analysts Medipharm Labs (Otc)’s price is currently Overvalued.
Does Medipharm Labs (Otc) pay dividends?
Medipharm Labs (Otc) does not currently pay dividends.
What is Medipharm Labs (Otc)’s EPS estimate?
Medipharm Labs (Otc)’s EPS estimate is 0.
How many shares outstanding does Medipharm Labs (Otc) have?
Medipharm Labs (Otc) has 420,755,000 shares outstanding.
What happened to Medipharm Labs (Otc)’s price movement after its last earnings report?
Medipharm Labs (Otc) reported an EPS of -C$0.01 in its last earnings report, missing expectations of -C$0.002. Following the earnings report the stock price went down -11.111%.
Which hedge fund is a major shareholder of Medipharm Labs (Otc)?
Currently, no hedge funds are holding shares in TSE:LABS
Company Description
Medipharm Labs (Otc)
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
LABS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects positive trends in financial performance, especially with record gross profit and strong international growth. However, it is overshadowed by challenges in the Canadian market and significant concerns over activist shareholder issues. This creates a mixed outlook, with strong operational performance but potential strategic risks.View all TSE:LABS earnings summariesTechnical Analysis
iAnthus Capital Holdings
―
Ayr Wellness
―
Decibel Cannabis Company
―
Vext Science
―
Avicanna
―
Options Prices
Currently, No data available
---